ECM1P2

Across TCGA pan-cancer cohorts, ECM1P2 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated ECM1P2 data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher ECM1P2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ECM1P2 expression acts as an unfavorable survival marker, although some lineages such as KIRC show a favorable association.

READ, ACC, and COAD are the cancer types where ECM1P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	OS	Tertile	II,III,IV	0.111	0.919	<.001	135	view →
ACC	OS	Tertile	All	0.151	0.835	<.001	57	view →
COAD	OS	Tertile	IV	0.183	0.670	.003	36	view →
BRCA	DFS	Tertile	All	0.889	0.952	.008	33	view →
BLCA	DFS	Tertile	All	0.440	0.630	.041	18	view →
KIRC	DFS	Tertile	All	1.000	0.848	.036	18	view →
HNSC	DFS	Tertile	IV	0.232	0.590	.010	12	view →
UCEC	OS	Tertile	All	0.876	0.929	.021	6	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

ECM1P2–READ (OS)

Open the READ breakdown →